
Johnson & Johnson Braces for First Vaginal Mesh Trial
The first vaginal mesh trial against New Jersey-based Johnson & Johnson is scheduled to begin in January 2013.
The first vaginal mesh trial against New Jersey-based Johnson & Johnson is scheduled to begin in January 2013.
Australia's Herald Sun is reporting that up to 20,000 women may be able to join what might possibly be the nation's largest-ever class action lawsuit.
Seven more people have filed lawsuits against Stryker Orthopedics alleging they were sold defective hip replacement products, among other accusations.
A multidistrict litigation has been established to consolidate all lawsuits filed against Coloplast Corp. over injuries allegedly caused by the company's vaginal mesh.
A West Virginia jury has returned a landmark $5.5 million verdict to a woman who alleged she was seriously injured by C.R. Bard's Avaulta Plus transvaginal mesh.
The New Jersey-based medical device maker has voluntarily recalled its Rejuvenate and ABG II modular-neck hip stem implants due to worries of premature device failure.
The bellwether trial of the class action alleging Johnson and Johnson's DePuy ASR hip implant caused patients serious injuries will begin later this year.
Nearly 1,500 women have signed an online petition meant to help create awareness for the serious health problems associated with the intrauterine device Mirena.
An FDA advisory group will thoroughly investigate the pros and risks associated with controversial metal-on-metal hip implants June 27 and 28.
The NJ-based pharmaceutical giant has reserved $600 million to potentially settle lawsuits alleging the company paid Omnicare to buy more lots of schizophrenia drugs.